Lena Eliasson

Lund University

Key Publications
Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II–Associated Non–Islet Cell Tumor Hypoglycemia
The Journal of Clinical Endocrinology & Metabolism, 2024
Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells
PLoS ONE, 2024
IGFBP7 is upregulated in islets from T2D donors and reduces insulin secretion
iScience, 2024
IGFBP7 is upregulated in islets from T2D donors and reduces insulin secretion
Mendeley Data, 2024
IGFBP7 is upregulated in islets from T2D donors and reduces insulin secretion
Mendeley Data, 2024

The research by Lena Eliasson aims to understand the pathogenesis of diabetes. She investigates cellular mechanisms underlying impaired insulin- and glucagon-secretion from pancreatic islet β- and α-cells, respectively. The focus is on single cell physiology and molecular biology involving studies of ion-channels, exocytosis and miRNA-mRNA-protein networks important in the regulation of islet cell function.

Last updated: 2025-03-11

Content Responsible: Hampus Pehrsson Ternström(hampus.persson@scilifelab.uu.se)

Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.
Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.